Trial Information

Summary: Psoriasis

The purpose of this study is to determine the efficacy and safety of switching to the study drug after experiencing a sub-optimal response to prior systemic or photo therapies.

Study drug and study procedures will be made available to you at no cost.

Patient Inclusion Criteria:

To qualify, you must:

• Be at least 18 years old
• Be diagnosed with chronic plaque psoriasis for at least 6 months
• Have had a sub-optimal response to treatment with prior systemic or photo therapies
• Be able to self-administer or has a qualified designee who can reliably administer injections.

Patient Exclusion Criteria: 

You will not qualify if you:

• Are pregnant or breast-feeding
• Have been treated with systemic corticosteroids (oral or routes other than oral such as injections) 4 weeks prior to joining this study
• Have received any experimental drug or device within the last 30 days
• Have a history of moderate to severe congestive heart failure

If you would like to learn more about participating in this study, please send an e-mail message using the form below.